Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
4.410
-0.100 (-2.22%)
Jul 18, 2025, 12:35 PM - Market open

Olema Pharmaceuticals Stock Forecast

OLMA's stock price has decreased by -69.28% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 4 analysts that cover Olema Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $24.5, which forecasts a 456.82% increase in the stock price over the next year. The lowest target is $18 and the highest is $30.

Price Target: $24.5 (+456.82%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$18$24.5$28$30
Change+309.09%+456.82%+536.36%+581.82%
* Price targets were last updated on May 14, 2025.

Analyst Ratings

The average analyst rating for Olema Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy321222
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total543444

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$20$18
Strong BuyMaintains$20$18+309.09%May 14, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$25$22
BuyMaintains$25$22+400.00%May 14, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong BuyReiterates$30+581.82%Apr 28, 2025
JP Morgan
JP Morgan
Buy
Maintains
$30$28
BuyMaintains$30$28+536.36%Mar 28, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$30$25
BuyReiterates$30$25+468.18%Mar 19, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 340.22M
Revenue Next Year
n/a
EPS This Year
-1.74
from -2.20
EPS Next Year
-1.97
from -1.74
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027FY 2028FY 2029
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027Dec 31, 2028Dec 31, 2029
Revenue
-3.83M30.27M157.49M340.22M
Revenue Growth
--691.40%420.27%116.03%---
EPS
-3.42-1.80-2.62-2.14-2.20-1.74-1.97-1.79
EPS Growth
--------
Forward PE
--------
No. Analysts
-----1096
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/a23.6M52.5M
Avgn/a3.8M30.3M
Lown/an/a13.9M

Revenue Growth

Revenue Growth20252026202720282029
High--
1,272.5%
Avg--
691.4%
Low--
263.9%

EPS Forecast

EPS202520262027
High-1.61-1.49-1.63
Avg-1.74-1.97-1.79
Low-2.19-2.18-1.84

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.